# Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)

> **NCT02805881** · NA · COMPLETED · sponsor: **Neurolief Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DEVICE:** Neurolief system

## Key facts

- **NCT ID:** NCT02805881
- **Lead sponsor:** Neurolief Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2021-07
- **Final completion:** 2021-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02805881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02805881, "Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02805881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*